EFFECTS OF MANNITOL ON LIPID PEROXIDATION AND Na+-K+/ATPase ENZYME ACTIVITY IN EXPERIMENTAL HEAD TRAUMA

Yıl 2010, Cilt: 17 Sayı: 3, 7 - 12, 30.09.2010

Mehmet Aköz

Öz

ABSTRACT
This study was designed to determine the effects of mannitol on tissue Na+/K+-ATP ase enzyme activity and malondialdehyde (MDA) levels in rabbit brain after experimental head trauma. Thirty New Zealand rabbits were divided equally into three groups: Group S(sham-operated group), group C(untreated group) and group M (mannitol treated group). Grup C and group M received head trauma with the weight drop method. Mannitol was administered 1.0 g/ kg i.v. immediately after the head trauma to group M. Head trauma was applied to the right side. One hour after trauma, brain cortices were resected from both sides and the Na+/K+-ATP ase enzyme activity and MDA levels were determined. The results were compared between S, M and C groups (p>0.05). Rectal temparature after the administration of mannitol in group M was found to be lower than groups S and C (p<0.05). [One-way ANOVA test was used for the statistical analysis.]
We conclude that Na+/K+-ATP ase activities were increased and MDA levels were decreased in mannitol treated rabbits but the differences were not statistically significant.

Key Words: Mannitol, Head trauma, Na+/K+-ATP ase, Malondialdehyde.

Anahtar Kelimeler

Mannitol, Kafa travmasi, Na+/K+-ATPaz, Malondialdehyde

Kaynakça

• Clifton GL, Robertson CS, Grossman RG, Hodge S, Foltz R, Garza C. The metabolic response to severe head injury. J Neurosurg. 1984 Apr;60(4):687-96.
• Rabow L, DeSalles AF, Becker DP, Yang M, Kontos HA, Ward JD, et al. CSF brain creatine kinase levels and lactic acidosis in severe head injury. J Neurosurg. 1986 Nov;65(5):625-9.
• Shapira Y, Yadid G, Cotev S, Shohami E. Accumulation of calcium in the brain following head trauma. Neurol Res. 1989 Sep;11(3):169-72.
• Bullock R,Lyeth BG, Muizelaar JP. Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies. Neurosurgery.1999;45:207-217.
• Bullock R, Zauner A, Woodward JJ, Myseros J, Choi SC, Ward JD, Marmarou A, Young HF. Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg. 1998 Oct;89(4):507-18.
• Ikeda Y, Long DM. The molecular basis of oxygen free radicals. Neurosurgery. 1990;27:1-11.
• Kiwak KJ, Moskowitz MA, Levine L. Leukotriene production in gerbil brain after ischemic insult, subarachnoid hemorrhage, and concussive injury. J Neurosurg. 1985 Jun;62(6):865-9.
• White BC, Sullivan JM, DeGracia DJ, O'Neil BJ, Neumar RW, Grossman LI, Rafols JA, Krause GS.
• Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci. 2000 Oct 1;179(S 1- 2):1-33.
• De Salles AF, Muizelaar JP, Young HF. Hyperglicemia cerebrospinal fluid lactic acidosis and cerebral blood flow in in severely head injured patients. Neurosurgery. 1987;21:45-50.
• Peters T. Calcium in physiological and pathological cell function. Eur Neurol. 1986;25:27-44.
• Trigle DJ. Calcium antagonists:history and perspective. Stroke. 1990;21:49-58.
• Gutteridge JM, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci.1990;15:129-135.
• Kirsch JR, Helfaer MA, Lange DG, Traystman RJ. Evidence for free radical mechanisms of brain injury resulting from ischemia/reperfusion-induced events. J Neurotrauma. 1992;23(10):1479-85.
• Hall ED. Free radicals and CNS injury. Crit Care Clin.1989;5(4):793-805.
• Callaway JK, Beart PM, Jarrott B. A reliable procedure for comparison of antioxidants in rat brain homogenates. J Pharmacol Toxicol Methods.1998;39:155-162.
• Drapper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods in enzymology. 1990;186;421-430.
• Halliwell B Chiroce S. Lipid peroxidation it’s mechanism measurement and signifiance. Am J Clin. 1993;57:715-25.
• Bereczki D, Mihálka L, Szatmári S, Fekete K, Di Cesar D, Fülesdi B, Csiba L, Fekete I. Mannitol use in acute stroke: case fatality at 30 days and 1 year. Stroke. 2003 Jul;34(7):1730-5.
• Desesso JM, Scialli AR, Goeringer GC. D-mannitol, a specific hydroxyl free radical scavenger, reduces the developmental toxicity of hydroxyurea in rabbits. Teratology. 1994 Apr;49(4):248-59.
• Christopher SG. The treatment of brain injury. United States Patents. 1996;(5):527- 533.
• Feeney DM, Boyeson MG, Linn RT, Murray HM, Dail WG. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res. 1981 Apr 27;211(1):67-77.
• Lowry OH, Rosebrough NJ, Farr WL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-272.
• Kitao T, Hattori K. Inhibition of erythrocyte ATPase activity by aclacynomycin and reverse effect of ascorbate on ATPase activity. Experientia. 1983;39:1362-64.
• Tyurin VA, Tyurina YY, Borisenko GG, Sokolova TV, Ritov VB, Quinn PJ, et al. Oxidative stress following traumatic brain injury in rats: quantitation of biomarkers and detection of free radical intermediates. J Neurochem. 2000 Nov;75(5):2178-89.
• Hall ED, Braughler JM. Free radicals in CNS injury. Res Publ Assoc Res Nerv Ment Dis.1993;71:81-105.
• Cauzinille L. Cranio-Cerebral Trauma: What and When to Decide. 26th WSAVA Congress Proceedings. August 8-11, 2001 Vancouver, British Columbia, Canada.
• Betz AL, Ennis SR, Schielke GP, Hoff JT. Blood-to- brain sodium transport in ischemic brain edema. Adv Neurol. 1990; 52: 73-80.
• Mendelow AD, Teasdale GM, Russell T, Flood J, Patterson J, Murray GD. Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human head injury. J Neurosurg. 1985 Jul;63(1):43-8.
• Maioriello AV, Chaljub G, Nauta HJ, Lacroix M. Chemical shift imaging of mannitol in acute cerebral ischemia. Case report. J Neurosurg. 2002 Sep;97(3):687-91.
• Bullock R. Mannitol and other diuretics in severe neurotrauma. New Horiz 1995;3(3):448-52.
• Schierhout G, Roberts I. Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev 2000;(2):CD001049.
• Brain Trauma Foundation. The use of mannitol severe head injury. J Neurotrauma 1996;13(11):705-9.
• Stover JF, Morganti-Kosmann MC, Lenzlinger PM, Stocker R, Kempski OS, Kossmann T. Glutamate and taurine are increased in ventricular cerebrospinal fluid of severely brain-injured patients. J Neurotrauma. 1999;16:135-142.
• Muir KW. Less KR. Clinical experience with excitatory amino acid antagonist drugs. Stroke.1995;26:503-513.
• Koura SS, Doppenberg EM, Marmarou A, Choi S, Young HF, Bullock R. Relationship between excitatory amino acid release and outcome after severe human head injury. Acta Neurochir Suppl. 1998;71:244-6.
• Ustün ME, Gürbilek M, Ak A, Vatansev H, Duman A. Effects of magnesium sulfate on tissue lactate and malondialdehyde levels in experimental head trauma. Intensive Care Med. 2001;27:264-68.
• Katayama Y, Fukuchi T, Mc Kee A, Terashi A. Effect of hyperglisemia on pyruvate dehyrogenase activity and energy metabolites during ischemia and reperfusion in geril brain. Brain Res. 1998;788:302-304.
• Damas, Hans P. Management of severely head injured patients during the first 24 hours. Which spesific therapeutics? Ann Fr Anesth Reanim. 2000;19(4):326- 32.
• Bereczki D, Liu M, do Prado GF, Fekete I. Mannitol for acute stroke. Cochrane Database Syst Rev 2001;(1):CD001153.